<DOC>
	<DOCNO>NCT00819507</DOCNO>
	<brief_summary>The purpose study determine effect short-term therapy use `` VANOS Cream , '' super-potent topical steroid cream skin barrier function patient atopic dermatitis . This cream already approve indication , investigator examine effect skin barrier . This cream novel formulation fluocinonide design enhance compliance cream base , skin barrier repair property ointment .</brief_summary>
	<brief_title>VANOS Cream Skin Barrier Function</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Fluocinonide</mesh_term>
	<criteria>Diagnosis AD accord HanifinRajka criterion ( see Appendix B ) Age 12 year old Must Investigator 's Global Assessment ( IGA ) Score Moderate , Severe , Very Severe ( See Appendix C ) Must fail achieve adequate disease despite adequate topical systemic therapy Must candidate , accord principal investigator standard care , superpotent topical steroid course . Subjects candidate superpotent topical steroid define subject whose disease adequately control mediumpotency topical steroid systemic therapy , include phototherapy . Active skin infection Hypersensitivity ingredients Vanos cream Previous use superpotent topical steroid within 2 week start study ( Class I steroid ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Skin barrier</keyword>
	<keyword>Atopic Dermatitis</keyword>
	<keyword>Corticosteroid</keyword>
	<keyword>Effects skin severity barrier function</keyword>
</DOC>